Skip to content

Du Meridian Acupuncture for the Treatment of Post-Stroke Motor Dysfunction in Ischemic Stroke Patients: An Explanatory Randomized Controlled Trial in the Lingnan Region.

Du Meridian Acupuncture for the Treatment of Post-Stroke Motor Dysfunction in Ischemic Stroke Patients: An Explanatory Randomized Controlled Trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2025002471
Enrollment
Unknown
Registered
2025-12-24
Start date
2025-12-31
Completion date
Unknown
Last updated
2026-01-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ischemic Stroke

Interventions

Conventional Acupuncture Group:Conventional acupuncture treatment combined with basic therapy and rehabilitation training. For upper limb motor dysfunction: Jianyu (LI15), Quchi (LI11), Waiguan (TE5),
DU Meridian Acupuncture Group:Based on conventional acupuncture group treatment, add DU Meridian acupuncture at Shenting (GV24), Baihui (GV20), Fengfu (GV16), and Dazhui (GV14). Retain needles for 30

Sponsors

Guangzhou University of Traditional Chinese Medicine First Affiliated Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
40 Years to 75 Years

Inclusion criteria

Inclusion criteria: (1) Patients must meet the diagnostic criteria of both Western medicine and Traditional Chinese Medicine, with a disease course of more than 2 weeks but less than 6 months, and be in the recovery phase; (2) All patients must have no history of ischemic or hemorrhagic stroke prior to this incident, and this must be their first occurrence; (3) Patients must be aged between 40 and 75 years old; (4) The infarct lesion must be located in the unilateral motor pathway (unilateral basal ganglia and/or corona radiata); (5) Blood pressure must be stable below 160/100 mmHg; (6) Motor dysfunction must be related to ischemic stroke, and there must be no prior motor dysfunction caused by other diseases before the stroke; (7) Unilateral limb motor dysfunction must be present (simplified FMA score <99 points); (8) Vital signs must be stable, with no language or hearing impairments, and patients must be able to cooperate with treatment; (9) Patients must be willing to accept the treatment plan of this study, voluntarily participate in the research, and sign the informed consent form; (10) All patients must be determined to be right-handed according to the Edinburgh Handedness Inventory; (11) Patients must have a relatively stable condition and be able to cooperate with MRI scans and clinical data collection; (12) Patients must not have taken psychotropic drugs in the past month; (13) Patients must have no contraindications for MRI examinations. All patients must meet the above 13 criteria.

Exclusion criteria

Exclusion criteria: (1) Those with a history of hemorrhagic stroke and ischemic stroke; (2) Those with severe primary diseases such as heart, lung, liver, gallbladder, kidney, pancreas, hematopoietic system diseases, and malignant tumors; (3) Those with poor compliance or severe aphasia, severe hearing impairment, intellectual disability, or comprehension that make it impossible to cooperate with the treatment plan; (4) Those with intracranial aneurysms, vascular malformations, or brain tumors; (5) Patients with severe brain dysfunction; (6) Those with hemoglobin below 100 g/L, platelet count less than 100 × 109/L, or international normalized ratio (INR) greater than 1.5 (irreversible), with uncorrectable bleeding factors; (7) Those with severe spinal deformities that affect acupuncture at the Governor Vessel; (8) Those with contraindications for MRI examinations, such as implanted metal devices or claustrophobia; (9) Those with severe intracranial anatomical asymmetry or clear lesions found in MRI scan results. If any of the above applies, exclusion is warranted.

Design outcomes

Primary

MeasureTime frame
Fugl-Meyer Limb Function Score;

Secondary

MeasureTime frame
National Institutes of Health Stroke Scale;Modified Barthel Index;Serum Vasoactive intestinal polypeptide;Serum Substance P;Functional Magnetic Resonance Imaging;

Countries

China

Contacts

Public ContactHe Jun

Guangzhou University of Traditional Chinese Medicine First Affiliated Hospital

895150145@qq.com13728020800

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026